GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,633,932 | +25.4% | 32,909 | +50.4% | 0.01% | +27.3% |
| Q2 2023 | $1,302,795 | +2.6% | 21,881 | -2.4% | 0.01% | 0.0% |
| Q1 2023 | $1,270,265 | -21.3% | 22,427 | +3.2% | 0.01% | -31.2% |
| Q4 2022 | $1,614,556 | +25.7% | 21,739 | +0.9% | 0.02% | +23.1% |
| Q3 2022 | $1,284,000 | -16.9% | 21,549 | -21.7% | 0.01% | -13.3% |
| Q2 2022 | $1,545,000 | -2.0% | 27,522 | +28.8% | 0.02% | +15.4% |
| Q1 2022 | $1,576,000 | +3.5% | 21,363 | +1.4% | 0.01% | +8.3% |
| Q4 2021 | $1,522,000 | -6.0% | 21,075 | -0.3% | 0.01% | -7.7% |
| Q3 2021 | $1,620,000 | -0.6% | 21,138 | +0.6% | 0.01% | 0.0% |
| Q2 2021 | $1,629,000 | +19.0% | 21,008 | -5.3% | 0.01% | +8.3% |
| Q1 2021 | $1,369,000 | -3.9% | 22,194 | +1.6% | 0.01% | -7.7% |
| Q4 2020 | $1,425,000 | +27.3% | 21,845 | -3.4% | 0.01% | +18.2% |
| Q3 2020 | $1,119,000 | +34.3% | 22,606 | +29.4% | 0.01% | -8.3% |
| Q2 2020 | $833,000 | +8.3% | 17,469 | -3.3% | 0.01% | -7.7% |
| Q1 2020 | $769,000 | -70.1% | 18,072 | -58.6% | 0.01% | -58.1% |
| Q4 2019 | $2,570,000 | +5.2% | 43,649 | -8.6% | 0.03% | +3.3% |
| Q3 2019 | $2,442,000 | +3.9% | 47,769 | -14.0% | 0.03% | +11.1% |
| Q2 2019 | $2,350,000 | -13.0% | 55,559 | +1.6% | 0.03% | -15.6% |
| Q1 2019 | $2,701,000 | +14.4% | 54,675 | +0.2% | 0.03% | +6.7% |
| Q4 2018 | $2,361,000 | -20.1% | 54,562 | +4.9% | 0.03% | +7.1% |
| Q3 2018 | $2,954,000 | +15.0% | 52,038 | +2.3% | 0.03% | +7.7% |
| Q2 2018 | $2,568,000 | +5.0% | 50,882 | +3.7% | 0.03% | +4.0% |
| Q1 2018 | $2,445,000 | +14.0% | 49,078 | -5.9% | 0.02% | +19.0% |
| Q4 2017 | $2,145,000 | +76.4% | 52,178 | +27.5% | 0.02% | +40.0% |
| Q3 2017 | $1,216,000 | +20.6% | 40,908 | +34.6% | 0.02% | +7.1% |
| Q2 2017 | $1,008,000 | +13.8% | 30,400 | +1.7% | 0.01% | +16.7% |
| Q1 2017 | $886,000 | +19.1% | 29,900 | -0.3% | 0.01% | +9.1% |
| Q4 2016 | $744,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |